Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Br J Haematol. 2021 May;193(4):692-696. doi: 10.1111/bjh.17402. Epub 2021 Mar 14.

Patrick Harrington^{1

2}, Claire N Harrison^{1

2}, Richard Dillon^{1

2}, Deepti H Radia¹, Katayoun Rezvani³, Kavita Raj¹, Claire Woodley¹, Natalia Curto-Garcia¹, Jennifer O'Sullivan¹, Jamie Saunders¹, Shahram Kordasti^{1

2}, Sahra Ali¹, Hugues de Lavallade^{1

2

4}, Donal P McLornan^{1

2}

¹ Department of Haematology, Guy's International Centre of Excellence in Myeloid Disorders, Guy's and St Thomas NHS Foundation Trust, London, UK.
² School of Cancer and Pharmaceutical Sciences, King's College, London, UK.
³ Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.

No abstract available

Keywords: CML; COVID-19; T cell; immunity; myeloproliferative neoplasm.

Publication types